Mitesco Stock Fundamentals
| MITI Stock | USD 0.46 0.14 23.33% |
Mitesco fundamentals help investors to digest information that contributes to Mitesco's financial success or failures. It also enables traders to predict the movement of Mitesco Pink Sheet. The fundamental analysis module provides a way to measure Mitesco's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mitesco pink sheet.
Mitesco |
Mitesco Company Return On Asset Analysis
Mitesco's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mitesco Return On Asset | -0.77 |
Most of Mitesco's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mitesco is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Mitesco has a Return On Asset of -0.7715. This is 91.18% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on asset for all United States stocks is notably higher than that of the company.
Mitesco Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mitesco's current stock value. Our valuation model uses many indicators to compare Mitesco value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mitesco competition to find correlations between indicators driving Mitesco's intrinsic value. More Info.Mitesco is considered to be number one stock in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mitesco by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mitesco's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Mitesco Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mitesco's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mitesco could also be used in its relative valuation, which is a method of valuing Mitesco by comparing valuation metrics of similar companies.Mitesco is currently under evaluation in return on asset category among its peers.
Mitesco Fundamentals
| Return On Equity | -16.52 | |||
| Return On Asset | -0.77 | |||
| Operating Margin | (17.97) % | |||
| Current Valuation | 22.43 M | |||
| Shares Outstanding | 4.63 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (8.88) X | |||
| Price To Book | 38.33 X | |||
| Price To Sales | 19.59 X | |||
| Revenue | 115.99 K | |||
| Gross Profit | (339.59 K) | |||
| EBITDA | (6.77 M) | |||
| Net Income | (7.92 M) | |||
| Cash And Equivalents | 35.82 K | |||
| Total Debt | 8.17 M | |||
| Debt To Equity | 4.62 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (1.73) X | |||
| Cash Flow From Operations | (5 M) | |||
| Earnings Per Share | (0.06) X | |||
| Target Price | 0.44 | |||
| Number Of Employees | 27 | |||
| Beta | 0.27 | |||
| Market Capitalization | 13.42 M | |||
| Total Asset | 10.65 M | |||
| Retained Earnings | (378.51 M) | |||
| Working Capital | 152.84 M | |||
| Current Asset | 187.66 M | |||
| Current Liabilities | 34.82 M | |||
| Z Score | -31.6 | |||
| Net Asset | 10.65 M |
About Mitesco Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mitesco's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mitesco using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mitesco based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 27 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Mitesco Pink Sheet
Mitesco financial ratios help investors to determine whether Mitesco Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mitesco with respect to the benefits of owning Mitesco security.